Legend Biotech Corp
NASDAQ:LEGN

Watchlist Manager
Legend Biotech Corp Logo
Legend Biotech Corp
NASDAQ:LEGN
Watchlist
Price: 39.89 USD 1.37% Market Closed
Market Cap: 7.4B USD
Have any thoughts about
Legend Biotech Corp?
Write Note

Legend Biotech Corp
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Legend Biotech Corp
Revenue Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Legend Biotech Corp
NASDAQ:LEGN
Revenue
$285.1m
CAGR 3-Years
56%
CAGR 5-Years
42%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Revenue
$55.5B
CAGR 3-Years
0%
CAGR 5-Years
11%
CAGR 10-Years
11%
Gilead Sciences Inc
NASDAQ:GILD
Revenue
$28.3B
CAGR 3-Years
1%
CAGR 5-Years
5%
CAGR 10-Years
3%
Amgen Inc
NASDAQ:AMGN
Revenue
$32.5B
CAGR 3-Years
8%
CAGR 5-Years
7%
CAGR 10-Years
5%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Revenue
$10.6B
CAGR 3-Years
14%
CAGR 5-Years
24%
CAGR 10-Years
30%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Revenue
$13.8B
CAGR 3-Years
1%
CAGR 5-Years
16%
CAGR 10-Years
18%

See Also

What is Legend Biotech Corp's Revenue?
Revenue
285.1m USD

Based on the financial report for Dec 31, 2023, Legend Biotech Corp's Revenue amounts to 285.1m USD.

What is Legend Biotech Corp's Revenue growth rate?
Revenue CAGR 5Y
42%

Over the last year, the Revenue growth was 144%. The average annual Revenue growth rates for Legend Biotech Corp have been 56% over the past three years , 42% over the past five years .

Back to Top